CLK Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of CLK monoclonal antibodies for applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CLK proteins are key regulators of alternative splicing and gene expression, making them central to understanding cellular processes and disease mechanisms. The role of CLK proteins extends to cell cycle regulation and stress response pathways, which has significant implications for cancer research and therapeutic development. CLK proteins influence multiple cellular pathways through their kinase activity, affecting RNA processing and protein synthesis. Understanding CLK protein function has led to important discoveries in developmental biology and disease progression. Researchers studying CLK-mediated signaling pathways rely on specific molecular tools to uncover new therapeutic targets. Recent studies have highlighted the importance of CLK proteins in neurodegenerative disorders and cancer development. Santa Cruz Biotechnology monoclonal antibodies for CLK research support scientists worldwide in their quest to advance medical breakthroughs and therapeutic innovations.